XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues $ 186,717 $ 256,513
Cost of goods sold 184,700 262,048
Gross (loss) profit 2,017 (5,535)
Research and development expenses 152 180
Selling, general and administrative expenses 39,266 28,686
Operating loss (37,401) (34,401)
Other expense (income):    
Interest rate expense 32,995 21,407
Debt related fees and amortization expense 6,524 7,363
Accretion and other expenses of Series A preferred units 25,313 9,888
Loss on debt extinguishment 0 49,386
Gain on litigation 0 (1,400)
Other income (2,077) (14,340)
Loss before income taxes (100,156) (106,705)
Income tax expense (benefit) (53,736) 1,053
Net loss (46,420) (107,758)
Other comprehensive (loss)    
Foreign currency translation loss (219) (1,102)
Comprehensive loss $ (46,639) $ (108,860)
Net loss per common share    
Basic (in dollars per share) $ (1.22) $ (3.12)
Diluted (in dollars per share) $ (1.22) $ (3.12)
Weighted average shares outstanding    
Basic (in shares) 38,061 34,585
Diluted (in shares) 38,061 34,585